Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

MJ Gleeson delivers cautious outlook after 'challenging year'

(Sharecast News) - Shares in MJ Gleeson fell on Friday after the low-cost, affordable housebuilder delivered a cautious outlook and announced a "reorganisation" of Gleeson Homes, which included the exit of its divisional chief executive and organisational changes. The company, which said it expects pre-tax profits for the year to 30 June to be in line with market forecasts of £21m-22.5m, said the housing market "lacks confidence and remains subdued".

"The board does not see a short-term catalyst for any substantial improvement," MJ Gleeson said.

For the FY2026 financial year, pre-tax profit is expected to come in at or around £24.5m, towards the lower end of current market expectations.

Chief executive Graham Prothero said FY25 was a "challenging year for Gleeson".

"As well as external factors, it had become clear that our commercial delivery was not where we needed it to be. Over the last nine months we have therefore been implementing at pace management changes which will significantly benefit the business through FY2026 and beyond," he said.

Those changes included the resignation of Gleeson Homes chief executive Mark Knight with immediate effect, along with the restructure of its six regional operations into two divisions: Central (covering Greater Manchester & Merseyside, Cumbria, Midlands and South/West Yorkshire) and Northern (covering East Yorkshire and Tees Valley/Tyne & Wear).

The reorganisation is expected to result in a £1.2m cash cost in its FY2025 results, recognised as an exceptional item.

Separately, Gleeson also announced that its interim chair Fiona Goldsmith, who has been in the position since April, has now been appointed as its permanent chair.

The stock was down nearly 6% at 365.3p by 1109 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.